Skip to content

Exploring Two Treatments for Misophonia

Exploring Two CBT-based Treatments as Interventions for Emotion Dysregulation in Misophonia

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04198597
Enrollment
12
Registered
2019-12-13
Start date
2020-09-11
Completion date
2022-11-21
Last updated
2022-11-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Misophonia

Brief summary

While the investigators continue to work on better understanding Misophonia, it is also important to identify treatments that can help people who are currently suffering. Further, it is important that the treatments provided are acceptable to the people who receive them. In this study, participants will complete one of two treatments the investigators believe can help manage symptoms of Misophonia: The Unified Protocol or process-based therapy. Both treatments will use evidence-based psychological principles (e.g., managing attention or behavior) in a flexible manner and will focus on developing skills to help reduce the distress and impairment associated with Misophonia. The aims of this study are (1) to explore the acceptability and feasibility of these treatments for individuals who experience Misophonia and (2) to examine whether these treatments help reduce symptoms associated with Misophonia.

Interventions

BEHAVIORALProcess-based Cognitive Behavioral Therapy

Please see arm/group descriptions

Sponsors

Duke University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Over age 18 * Able to read English * Meet criteria for interfering symptoms of misophonia * Live in North Carolina

Exclusion criteria

* Under age 18 * Current mania * Current psychotic disorder * Current anorexia * Presents with a condition that requires immediate prioritization in treatment (e.g., suicide planning or intent) * Has received any treatment specifically for misophonia in the past year

Design outcomes

Primary

MeasureTime frameDescription
Number of patients that are satisfied with treatment as measured by the credibility and expectancy questionnaire (CEQ)up to 20 weeksThe CEQ is a 6-item measure that asks patients about their perceptions of treatment.
Number of patients who indicate treatment was acceptable to them (i.e., the treatment approach made sense and was perceived as reasonable)up to 20 weeksThis form has two questions that assess how satisfied patients were with treatment and how acceptable treatment was to them. The remaining three items are open ended questions that allow patients to provide narrative feedback about their experience in treatment.

Secondary

MeasureTime frameDescription
Change in depression as measured by the Overall Depression Severity and Impairment Scaleassessed weekly, up to 24 weeksThe Overall Depression Severity and Impairment Scale is a five item measure that assesses interference and distress in an individual's day-to-day life related to the experience of depression. Items are scored from 0 to 4 and summed to produce a total score (ranging from 0 - 20), with higher scores indicating greater functional impairment.
Change in misophonia symptoms as assessed by the Misophonia Questionnaireassessed weekly, up to 24 weeksThe Misophonia Questionnaire is a 17-item questionnaire that assesses the presence of misophonia symptoms, emotions and behaviors associated with misophonic reactions, and symptom severity. The first two subscales are rated on a scale of 0 (not at all true) to 4 (always true). These two parts are summed to produce a total score ranging from 0 - 68. The severity subscale is a single item that asks an individual to provide a rating of their sound sensitivity on a scale from 0 (no sound sensitivities) to 15 (very severe sound sensitivities).
Number of patients who use the skills taught in treatment as measured by the Skill Use Questionnaireassessed weekly, up to 24 weeksThe Skill Use Questionnaire is a four-item measure that assesses the extent to which patients use the skills taught in therapy and find them to be helpful.
Change in anger as measured by the Clinical Anger Scaleassessed weekly, up to 24 weeksThe Clinical Anger Scale is a 21-item measure that assesses the severity of anger-related symptoms (e.g., current anger, anger about the future).Items are scored from 0 to 3 and summed to produce a total score (ranging from 0 - 63), with higher scores indicating greater anger-related symptoms.
Change in anxiety as measured by the Overall Anxiety Severity and Impairment Scaleassessed weekly, up to 24 weeksThe Overall Anxiety Severity and Impairment Scale is a five item measure that assesses interference and distress related to the experience of anxiety. Items are scored from 0 to 4 and summed to produce a total score (ranging from 0 - 20), with higher scores indicating greater functional impairment.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026